BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23437222)

  • 1. Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia.
    Zhi F; Cao X; Xie X; Wang B; Dong W; Gu W; Ling Y; Wang R; Yang Y; Liu Y
    PLoS One; 2013; 8(2):e56718. PubMed ID: 23437222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum level of miR-10-5p as a prognostic biomarker for acute myeloid leukemia.
    Zhi Y; Xie X; Wang R; Wang B; Gu W; Ling Y; Dong W; Zhi F; Liu Y
    Int J Hematol; 2015 Sep; 102(3):296-303. PubMed ID: 26134365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum extracellular vesicle miR-10b expression predicts poor prognosis in patients with acute myeloid leukemia.
    Fang Z; Wang X; Wu J; Xiao R; Liu J
    Cancer Biomark; 2020; 27(1):1-9. PubMed ID: 31594209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
    Huang Y; Zou Y; Lin L; Ma X; Chen H
    Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.
    Fayyad-Kazan H; Bitar N; Najar M; Lewalle P; Fayyad-Kazan M; Badran R; Hamade E; Daher A; Hussein N; ElDirani R; Berri F; Vanhamme L; Burny A; Martiat P; Rouas R; Badran B
    J Transl Med; 2013 Feb; 11():31. PubMed ID: 23391324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia.
    Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-638 in circulating leukaemia cells as a non-invasive biomarker in diagnosis, treatment response and MRD surveillance of acute promyelocytic leukaemia.
    Bai Y; Chen C; Guo X; Ding T; Yang X; Yu J; Yang J; Ruan J; Zheng X; Chen Z
    Cancer Biomark; 2020; 29(1):125-137. PubMed ID: 32568176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum miR-133 as a novel biomarker for predicting treatment response and survival in acute myeloid leukemia.
    Zheng ZZ; Ma YP; Wu RH; Rong G; Li C; Li GX; Ren FG; Xu LJ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):777-783. PubMed ID: 32016982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
    Zhou G; Lu M; Chen J; Li C; Zhang J; Chen J; Shi X; Wu S
    Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
    Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
    Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
    Lin X; Wang Z; Wang Y; Feng W
    Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
    Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
    Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
    Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
    PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-582-5p serves as an antioncogenic biomarker in intermediate risk AML with normal cytogenetics and could inhibit proliferation and induce apoptosis of leukemia cells.
    Wang X; Feng Y; Zhang P; Chen H; Bai J; Wang F; He A
    Cell Biol Int; 2020 Oct; 44(10):2021-2030. PubMed ID: 32543749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
    Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
    Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia.
    Yu G; Yin Z; He H; Zheng Z; Chai Y; Xuan L; Lin R; Wang Q; Li J; Xu D
    J Clin Lab Anal; 2020 Mar; 34(3):e23096. PubMed ID: 31691380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
    Guo Y
    Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
    Seipel K; Messerli C; Wiedemann G; Bacher U; Pabst T
    Leuk Res; 2020 Feb; 89():106296. PubMed ID: 31927137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-22 is a novel prognostic marker for acute myeloid leukemia.
    Qu H; Zheng G; Cheng S; Xie W; Liu X; Tao Y; Xie B
    J Clin Lab Anal; 2020 Sep; 34(9):e23370. PubMed ID: 32533562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of miR-181a and three HOXA genes as useful biomarkers in acute myeloid leukemia.
    Xu P; Zhou D; Yan G; Ouyang J; Chen B
    Int J Lab Hematol; 2020 Feb; 42(1):16-22. PubMed ID: 31670914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.